Experienced in Cerebellar Degeneration

Dr. Deborah A. Burke

Neurology
5 Tampa General Cir, Suite 410, 
Tampa, FL 
Accepting New Patients
Experienced in Cerebellar Degeneration
5 Tampa General Cir, Suite 410, 
Tampa, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Deborah Burke is a Neurologist in Tampa, Florida. Dr. Burke is rated as an Experienced provider by MediFind in the treatment of Cerebellar Degeneration. Her top areas of expertise are Parkinson's Disease, Movement Disorders, Lewy Body Dementia (LBD), and Cerebellar Degeneration. Dr. Burke is currently accepting new patients.

Her clinical research consists of participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurology
Licenses
Psychiatry & Neurology in FL
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

5 Tampa General Cir, Suite 410, Tampa, FL 33606

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: December 17, 2025
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
A Multicenter, Prospective, Longitudinal, Digital Assessment Study of Disease Progression in Subjects with Early, Untreated Parkinson Disease
A Multicenter, Prospective, Longitudinal, Digital Assessment Study of Disease Progression in Subjects with Early, Untreated Parkinson Disease
Enrollment Status: Completed
Publish Date: October 08, 2024
A Multicenter, Open Label Study to Evaluate Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Dementia.
A Multicenter, Open Label Study to Evaluate Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease Dementia.
Enrollment Status: Withdrawn
Publish Date: March 01, 2024
Intervention Type: Drug
Study Drug: ENT-01
Study Phase: Phase 1
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Drug
Study Drug: ENT-01
Study Phase: Phase 2
An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With Attention-Deficit/Hyperactivity Disorder
An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With Attention-Deficit/Hyperactivity Disorder
Enrollment Status: Completed
Publish Date: February 13, 2024
Intervention Type: Drug
Study Drug: SPN-812
Study Phase: Phase 3
The Parkinson's Progression Markers Initiative (PPMI)
The Parkinson's Progression Markers Initiative (PPMI)
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Drug
Study Drug: DaTscan
Study Phase: Phase 2
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Flexible-Dose Study of the Efficacy and Safety of SPN-812 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Flexible-Dose Study of the Efficacy and Safety of SPN-812 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Enrollment Status: Completed
Publish Date: July 12, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2a Combined Open-Label and Double-Blind, Placebo-Controlled Crossover Study Assessing the Effectiveness, Safety, and Tolerability of Oral Fasudil in Subjects With Dementia and Wandering Behaviors of Elopement and/or Getting Lost
A Phase 2a Combined Open-Label and Double-Blind, Placebo-Controlled Crossover Study Assessing the Effectiveness, Safety, and Tolerability of Oral Fasudil in Subjects With Dementia and Wandering Behaviors of Elopement and/or Getting Lost
Enrollment Status: Completed
Publish Date: July 11, 2022
Intervention Type: Drug
Study Drug: Oral Fasudil
Study Phase: Phase 2
View 8 Less Clinical Trials
Similar Doctors
Distinguished in Cerebellar Degeneration
Dr. Susan J. Steen
Neurology
Distinguished in Cerebellar Degeneration
Dr. Susan J. Steen
Neurology
2919 W Swann Ave, Suite 401, 
Tampa, FL 
 (2.0 miles away)
813-872-1548
Languages Spoken:
English
See accepted insurances

Susan Steen is a Neurologist in Tampa, Florida. Dr. Steen is rated as a Distinguished provider by MediFind in the treatment of Cerebellar Degeneration. Her top areas of expertise are Cerebellar Degeneration, Alzheimer's Disease, Memory Loss, and Lewy Body Dementia (LBD).

Distinguished in Cerebellar Degeneration
Dr. Richard J. Lichtenstein
Radiology | Neurology
Distinguished in Cerebellar Degeneration
Dr. Richard J. Lichtenstein
Radiology | Neurology

Tower Imaging LLC

2106 S Lois Ave, 
Tampa, FL 
 (3.5 miles away)
813-253-2721
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Richard Lichtenstein is a Radiologist and a Neurologist in Tampa, Florida. Dr. Lichtenstein is rated as a Distinguished provider by MediFind in the treatment of Cerebellar Degeneration. His top areas of expertise are Hepatocerebral Degeneration, Cerebellar Multiple System Atrophy, Cerebellar Degeneration, and Pleurisy. Dr. Lichtenstein is currently accepting new patients.

Distinguished in Cerebellar Degeneration
Dr. Rafael M. Rodriguez
Neurology
Distinguished in Cerebellar Degeneration
Dr. Rafael M. Rodriguez
Neurology

Neurophysiology Center P.A.

401 N Parson Ave, Suite 105, 
Brandon, FL 
 (10.6 miles away)
813-653-2775
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Rafael Rodriguez is a Neurologist in Brandon, Florida. Dr. Rodriguez is rated as a Distinguished provider by MediFind in the treatment of Cerebellar Degeneration. His top areas of expertise are Seizures, Trigeminal Neuralgia, Familial Neurocardiogenic Syncope, Cerebellar Degeneration, and Gastrostomy. Dr. Rodriguez is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Burke's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile